Merit Medical Systems Inc MMSI
1,001 filings, 2 in the last 30 days
SEC filing indexWhat the 8-Ks said
2 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Jan 8, 2026 CEO, CFO, COO or CAOCEO change “Lampropoulos’ employment as Executive Chair of the Board on January 3, 2026 pursuant to Merit’s CEO Transition Agreement, and his resignation as Merit’s President and Chief Executive Officer.” 8-K item 5.02 · all documents
- Jul 11, 2025 CEO, CFO, COO or CAOCEO change “On July 7, 2025, Merit announced the appointment of Martha Aronson as Merit’s President and Chief Executive Officer (“CEO”), effective October 3, 2025.” 8-K item 5.02 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 47 events
- Nov 14, 2026 SEC letter SEC asked 2 questions about Form 10-K for the Fiscal Year Ended December 31, 2017letters Mar 29, 2018 to Apr 20, 2018 · Russia and Ukraine, Revenue
- Oct 29, 2026 Planned sale Michel Voigt (Chief Human Resources Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 7,682 shares, runs to May 12, 2027
- Oct 29, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Oct 29, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Aug 24, 2026 Planned sale NEIL W PETERSON (Officer) gave notice of a planned sale of 7,500 shares worth about $678KForm 144, approximate sale date Aug 24, 2026
- Aug 20, 2026 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Aug 4, 2026 Planned sale NEIL W PETERSON (Officer) gave notice of a planned sale of 21,449 shares worth about $1.8MForm 144, approximate sale date Aug 4, 2026
- Jul 30, 2026 Planned sale Brian G. Lloyd (our Chief Legal Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 16,722 shares, runs to Feb 26, 2027
- Jul 30, 2026 Planned sale Raul Parra (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 50,646 shares, runs to May 26, 2028
- Jul 30, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Jul 30, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- May 19, 2026 8-K Director or officer change, Bylaws or fiscal year changed, Shareholder vote results, Regulation FD disclosure8-K items 5.02, 5.03, 5.07, 7.01
- May 7, 2026 Planned sale LYNNE WARD (Director) gave notice of a planned sale of 5,000 shares worth about $313KForm 144, approximate sale date May 7, 2026
- Apr 30, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Apr 30, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 13, 2026 8-K Regulation FD disclosure8-K item 7.01
- Apr 1, 2026 8-K Regulation FD disclosure8-K item 7.01
- Feb 24, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Feb 24, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Jan 8, 2026 Officer CEO changeLampropoulos’ employment as Executive Chair of the Board on January 3, 2026 pursuant to Merit’s CEO Transition Agreement, and his resignation as Merit’s President and Chief Executive Officer.
- Jan 6, 2026 Planned sale NEIL W PETERSON (Officer) gave notice of a planned sale of 5,000 shares worth about $450KForm 144, approximate sale date Jan 6, 2026, under a 10b5-1 plan adopted Nov 6, 2024
- Nov 25, 2025 Planned sale FRED LAMPROPOULOS (Director) gave notice of a planned sale of 10,000 shares worth about $880KForm 144, approximate sale date Nov 25, 2025
- Nov 21, 2025 Planned sale FRED LAMPROPOULOS (Director) gave notice of a planned sale of 25,000 shares worth about $2.2MForm 144, approximate sale date Nov 21, 2025
- Nov 20, 2025 Planned sale FRED LAMPROPOULOS (Director) gave notice of a planned sale of 20,000 shares worth about $1.7MForm 144, approximate sale date Nov 20, 2025
- Nov 18, 2025 Planned sale FRED LAMPROPOULOS (Director) gave notice of a planned sale of 5,000 shares worth about $424KForm 144, approximate sale date Nov 18, 2025
- Nov 13, 2025 8-K Regulation FD disclosure8-K item 7.01
- Nov 3, 2025 8-K Regulation FD disclosure8-K item 7.01
- Oct 30, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Oct 30, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Oct 17, 2025 8-K Regulation FD disclosure8-K item 7.01
- Oct 10, 2025 8-K Director or officer change8-K item 5.02
- Jul 30, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Jul 30, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jul 11, 2025 Officer CEO changeOn July 7, 2025, Merit announced the appointment of Martha Aronson as Merit’s President and Chief Executive Officer (“CEO”), effective October 3, 2025.
- May 20, 2025 8-K Material agreement signed, Quarterly results, Regulation FD disclosure8-K items 1.01, 2.02, 7.01
- May 19, 2025 8-K Shareholder vote results8-K item 5.07
- Apr 24, 2025 Planned sale David K. Floyd (member of our Board of Directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 5,021 shares, runs to Jun 2, 2026
- Apr 24, 2025 Planned sale Michael R. McDonnell (member of our Board of Directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 3,500 shares, runs to Jun 30, 2025
- Apr 24, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Apr 24, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Apr 14, 2025 10-K Annual report (10-K) (amended)period ended Dec 31, 2024
- Feb 25, 2025 Planned sale Neil Peterson (Chief Operating Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 15,000 shares, runs to Apr 24, 2026
- Feb 25, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Feb 25, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Jan 28, 2025 8-K Regulation FD disclosure8-K item 7.01
- Jan 14, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Dec 19, 2024 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Oct 29, 2026 | 10-Q | Quarterly report |
| Oct 29, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Sep 9, 2026 | 4 | Insider trade |
| Sep 1, 2026 | 3 | New insider |
| Aug 25, 2026 | 4 | Insider trade |
| Aug 25, 2026 | 4 | Insider trade |
| Aug 24, 2026 | 144 | Notice of planned insider sale |
| Aug 20, 2026 | 8-K | Director or officer change, Regulation FD disclosure |
| Aug 5, 2026 | 4 | Insider trade |
| Aug 4, 2026 | 144 | Notice of planned insider sale |
| Jul 30, 2026 | 10-Q | Quarterly report |
| Jul 30, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Jun 29, 2026 | S-8 | Shares registered for employee plans |
| Jun 26, 2026 | 11-K | Employee plan annual report |
| Jun 17, 2026 | 4 | Insider trade |
| Jun 8, 2026 | 4 | Insider trade |
| May 29, 2026 | SD | Conflict minerals report |
| May 21, 2026 | 4 | Insider trade |
| May 19, 2026 | 4 | Insider trade |
| May 19, 2026 | 4 | Insider trade |
| May 19, 2026 | 4 | Insider trade |
| May 19, 2026 | 4 | Insider trade |
| May 19, 2026 | 4 | Insider trade |
| May 19, 2026 | 4 | Insider trade |
| May 19, 2026 | 4 | Insider trade |
| May 19, 2026 | 4 | Insider trade |
| May 19, 2026 | 3 | New insider |
| May 19, 2026 | 4 | Insider trade |
| May 19, 2026 | 8-K | Director or officer change, Bylaws or fiscal year changed, Shareholder vote results, Regulation FD disclosure |
| May 15, 2026 | S-8 | Shares registered for employee plans |
| May 13, 2026 | 4 | Insider trade |
| May 11, 2026 | 4 | Insider trade |
| May 11, 2026 | 4 | Insider trade |
| May 7, 2026 | 144 | Notice of planned insider sale |
| May 7, 2026 | 4 | Insider trade |
| May 7, 2026 | 4 | Insider trade |
| May 7, 2026 | 4 | Insider trade |
| Apr 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 30, 2026 | 10-Q | Quarterly report |
| Apr 30, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Apr 29, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 13, 2026 | 8-K | Regulation FD disclosure |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 1, 2026 | 8-K | Regulation FD disclosure |
| Mar 31, 2026 | ARS | Annual report to shareholders |
| Mar 31, 2026 | DEFA14A | Extra proxy material |
| Mar 31, 2026 | DEF 14A | Proxy statement |
| Mar 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 2, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 4 | Insider trade |
| Feb 24, 2026 | 10-K | Annual report |
| Feb 24, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Jan 8, 2026 | 4 | Insider trade |
| Jan 8, 2026 | 8-K | Quarterly results, Director or officer change, Regulation FD disclosure |
| Jan 6, 2026 | 144 | Notice of planned insider sale |
| Nov 26, 2025 | 4 | Insider trade |
| Nov 25, 2025 | 144 | Notice of planned insider sale |
| Nov 24, 2025 | 4 | Insider trade |
| Nov 21, 2025 | 144 | Notice of planned insider sale |
| Nov 21, 2025 | 4 | Insider trade |
| Nov 20, 2025 | 144 | Notice of planned insider sale |
| Nov 20, 2025 | 4 | Insider trade |
| Nov 18, 2025 | 144 | Notice of planned insider sale |
| Nov 13, 2025 | 8-K | Regulation FD disclosure |
| Nov 3, 2025 | 8-K | Regulation FD disclosure |
| Oct 30, 2025 | 10-Q | Quarterly report |
| Oct 30, 2025 | 8-K | Quarterly results, Regulation FD disclosure |
| Oct 17, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 17, 2025 | 8-K | Regulation FD disclosure |
| Oct 10, 2025 | 8-K | Director or officer change |
| Oct 7, 2025 | 4/A | Insider trade (amended) |
| Oct 7, 2025 | 3/A | New insider (amended) |
| Oct 7, 2025 | 4 | Insider trade |
| Oct 7, 2025 | 3 | New insider |
| Sep 3, 2025 | 4 | Insider trade |
| Aug 25, 2025 | 4 | Insider trade |
| Aug 22, 2025 | 144 | Notice of planned insider sale |
| Aug 12, 2025 | 4 | Insider trade |
| Aug 11, 2025 | 144 | Notice of planned insider sale |
| Jul 30, 2025 | 10-Q | Quarterly report |
| Jul 30, 2025 | 8-K | Quarterly results, Regulation FD disclosure |
| Jul 11, 2025 | 8-K | Quarterly results, Director or officer change |
| Jun 27, 2025 | 11-K | Employee plan annual report |
| Jun 17, 2025 | 4 | Insider trade |
| Jun 13, 2025 | 144 | Notice of planned insider sale |
| Jun 12, 2025 | 4 | Insider trade |
| Jun 11, 2025 | 3 | New insider |
| Jun 10, 2025 | 144 | Notice of planned insider sale |
| Jun 9, 2025 | 4 | Insider trade |
| Jun 5, 2025 | 144 | Notice of planned insider sale |
| Jun 3, 2025 | 4 | Insider trade |
| Jun 3, 2025 | 4 | Insider trade |
| Jun 3, 2025 | 4 | Insider trade |
| Jun 3, 2025 | 4 | Insider trade |
| Jun 2, 2025 | 144 | Notice of planned insider sale |
| May 30, 2025 | 144 | Notice of planned insider sale |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MMSI/export.csv") into a cell.